These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2447609)

  • 1. [Sex steroid hormones and growth factors--growth of the prostate].
    Matuo Y; Nishi N; Wada F
    Tanpakushitsu Kakusan Koso; 1987 Aug; 32(9):1126-32. PubMed ID: 2447609
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
    Joseph IB; Nelson JB; Denmeade SR; Isaacs JT
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphotyrosine antibodies preferentially react with basal epithelial cells in the dog prostate.
    Landry F; Chapdelaine A; Bégin LR; Chevalier S
    J Urol; 1996 Jan; 155(1):386-90. PubMed ID: 7490893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor receptor 2 tyrosine kinase is required for prostatic morphogenesis and the acquisition of strict androgen dependency for adult tissue homeostasis.
    Lin Y; Liu G; Zhang Y; Hu YP; Yu K; Lin C; McKeehan K; Xuan JW; Ornitz DM; Shen MM; Greenberg N; McKeehan WL; Wang F
    Development; 2007 Feb; 134(4):723-34. PubMed ID: 17215304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratinocyte growth factor expression in hormone insensitive prostate cancer.
    Leung HY; Mehta P; Gray LB; Collins AT; Robson CN; Neal DE
    Oncogene; 1997 Aug; 15(9):1115-20. PubMed ID: 9285567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of prostate anatomy, histology, and pathology.
    Lee CH; Akin-Olugbade O; Kirschenbaum A
    Endocrinol Metab Clin North Am; 2011 Sep; 40(3):565-75, viii-ix. PubMed ID: 21889721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of oxytocin on cell proliferation in the human prostate is modulated by gonadal steroids: implications for benign prostatic hyperplasia and carcinoma of the prostate.
    Whittington K; Connors B; King K; Assinder S; Hogarth K; Nicholson H
    Prostate; 2007 Jul; 67(10):1132-42. PubMed ID: 17492653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine control of prostate cancer.
    Wilding G
    Cancer Surv; 1995; 23():43-62. PubMed ID: 7621473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Culturing of normal and tumor cells of the human prostate].
    Cussenot O; Teillac P; Le Duc A; Ketels F; Calvo F
    Ann Urol (Paris); 1989; 23(6):533-7. PubMed ID: 2482701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.
    Platz EA; Giovannucci E
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):237-53. PubMed ID: 15663987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary culture as an in vitro model.
    Merchant DJ
    Prog Clin Biol Res; 1987; 239():473-95. PubMed ID: 2443915
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of growth factors in the pathogenesis of BPH.
    Habib FK
    Prog Clin Biol Res; 1994; 386():43-50. PubMed ID: 7528412
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia.
    Soulitzis N; Karyotis I; Delakas D; Spandidos DA
    Int J Oncol; 2006 Aug; 29(2):305-14. PubMed ID: 16820871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.
    Polnaszek N; Kwabi-Addo B; Wang J; Ittmann M
    Prostate; 2004 Jun; 60(1):18-24. PubMed ID: 15129425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid receptors in prostate cancer tissues and cells: pathophysiology, problems in methodology, clinical value and controversial questions.
    Pavone-Macaluso M; Carruba G; Castagnetta L
    Arch Esp Urol; 1994 Mar; 47(2):189-201. PubMed ID: 8002681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro models: organ explant culture of normal and neoplastic human prostate.
    Heatfield BM
    Prog Clin Biol Res; 1987; 239():391-471. PubMed ID: 2443914
    [No Abstract]   [Full Text] [Related]  

  • 19. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
    Bonkhoff H; Remberger K
    Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New aspects in histogenesis of hyperplasia and cancers of the prostate].
    Bonkhoff H; Remberger K
    Verh Dtsch Ges Pathol; 1993; 77():31-9. PubMed ID: 7511302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.